- NYSE:GE added 4.66% on Tuesday alongside a broader market rally that saw the Dow’s best day in three months.
- A Bank of America analyst upgraded General Electric on some serious 2021 tailwinds.
- GE Healthcare won the award for the 2020 Global Company of the Year.
NYSE:GE has continued to claw its way back to relevance in 2021 after years of bleeding through its cash reserves. On Tuesday, General Electric gained 4.66% to close the trading session at $11.24 as the broader markets rebounded after a week of uncertainty from the r/WallStreetBets standoff. With the surge on Tuesday, GE is once again trading over its 50-day moving average and is now within reach of eclipsing its 52-week high price of $13.26, which the stock has not seen since before the outbreak of the COVID-19 pandemic.
On Monday, General Electric received a nice upgrade from an analyst at Bank of America, which raised his price target for the iconic American company to $14. The analyst, Andrew Orbin, cited significant tailwinds for 2021 which include an emphasis on renewable energies, a rebound of the commercial aviation industry, as well as strong guidance for between $2.5 billion and $4.5 billion in free cash flow. The $14 price target from Orbin represents a 25% premium on the closing price from Tuesday.
GE stock price forecast
General Electric’s healthcare division received a well-deserved honour recently as it was named the 2020 Global Company of the Year. The award is specifically for GE’s global healthcare command centers that support regional med-tech solutions, particularly during the recent COVID-19 pandemic. While General Electric is not usually noted or its healthcare branch, it should be good news to shareholders that the company’s other divisions are doing well at a time where the aviation department is slumping.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD: Some contention seems to have emerged near 0.6500
Another day, another pullback in AUD/USD. This time the pair dropped to multi-week lows and approached the key 0.6500 support, always on the back of weak commodity prices and concerns surrounding the Chinese economy.
EUR/USD: Downside halted near the 200-day SMA
EUR/USD regained some balance and left behind two consecutive daily declines, advancing to the 1.0870 region following the indecisive price action in the US Dollar ahead of key PCE data due on Friday.
Gold challenges critical support
Gold remains under selling pressure on Thursday, trading near a fresh multi-week low of $2,357.92. The bright metal eased throughout the first half of the day amid a dismal market mood. Equities led the way, falling on the back of weak earning reports and a sharp slide in the tech sector.
SEC vs. Ripple lawsuit closed-door meeting could result in resolution, XRP hovers around $0.62
Ripple hovers above key support at $0.62 as traders await a resolution in the US Securities & Exchange Commission lawsuit. The meeting is scheduled to occur behind closed doors on July 25. According to pro-crypto attorney Fred Rispoli, the lawsuit against Ripple could end by July 2024.
Buying on a market decline
In today’s TradeGATEHub Live Trading session, Coach Dale inquires about the specific issues Michael Venezia was buying during the recent market decline. Dale also provides a detailed analysis of precious metals, sharing his insights on potential downside targets.